A PROSPECTIVE OBSERVATIONAL STUDY ON DRUG USED IN POLYCYSTIC OVARIAN SYNDROME IN WARANGAL REGION

Main Article Content

Gk.Chandhana
T.Sai Sri Vaishnavi
Ch. Shivani
Dr.Y Karnakar Reddy
Dr B.Agaiah Goud

Keywords

.

Abstract

Polycystic Ovarian Syndrome (PCOS), also referred to as hyperandrogenic anovulation (HA), or Stein–Leventhal syndrome , is one of the most common endocrine system disorders that affect women in their reproductive age . Since it is described by Stein and Leventhal in 1935.


Polycystic ovary syndrome (PCOS) is a complex condition characterized by elevated androgen levels, menstrual irregularities, and small cysts in one or both ovaries. The disorder can be morphological (polycystic ovaries) or predominantly biochemical (hyperandrogenemia).

Abstract 38 | pdf Downloads 38

References

1. El Hayek, Samer et al. “Poly Cystic Ovarian Syndrome: An Updated Overview.” Frontiers in physiology vol. 7 124. 5 Apr. 2016, doi:10.3389/fphys.2016.00124.Accessed March 23,2022[ Front Physiol. 2016; 7: 124.Published online 2016 Apr 5]Frontiers in Physiology.
2. Sirmans, Susan M, and Kristen A Pate. “Epidemiology, diagnosis, and management of polycystic ovary syndrome.” Clinical epidemiology vol. 6 1-13. 18 Dec. 2013, doi:10.2147/CLEP.S37559. Accessed march 20, 2022[Clinical Epidemiology. 2014; 6: 1–13.Published online 2013 Dec 18]Dove press.
3. El Hayek, Samer et al. “Poly Cystic Ovarian Syndrome: An Updated Overview.” Frontiers in physiology vol. 7 124. 5 Apr. 2016, doi:10.3389/fphys.2016.00124Accessed march 21, 2022[ Front Physiol. 2016; 7: 124.Published online 2016 Apr 5]Frontiers in Physiology.
4. Ganie, Mohammad Ashraf et al. “Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.” The Indian journal of medical research vol. 150,4 (2019): 333-344. doi:10.4103/ijmr.IJMR_1937_17. Accessed march 22, 2022[Indian J Med Res. 2019 Oct; 150(4): 333–344].